Literature DB >> 21398519

Difference in stability of the N-domain underlies distinct intracellular properties of the E1064A and H1069Q mutants of copper-transporting ATPase ATP7B.

Oleg Y Dmitriev1, Ashima Bhattacharjee, Sergiy Nokhrin, Eva-Maria E Uhlemann, Svetlana Lutsenko.   

Abstract

Wilson disease (WD) is a disorder of copper metabolism caused by mutations in the Cu-transporting ATPase ATP7B. WD is characterized by significant phenotypic variability, the molecular basis of which is poorly understood. The E1064A mutation in the N-domain of ATP7B was previously shown to disrupt ATP binding. We have now determined, by NMR, the structure of the N-domain containing this mutation and compared properties of E1064A and H1069Q, another mutant with impaired ATP binding. The E1064A mutation does not change the overall fold of the N-domain. However, the position of the α1,α2-helical hairpin (α-HH) that houses Glu(1064) and His(1069) is altered. The α-HH movement produces a more open structure compared with the wild-type ATP-bound form and misaligns ATP coordinating residues, thus explaining complete loss of ATP binding. In the cell, neither the stability nor targeting of ATP7B-E1064A to the trans-Golgi network differs significantly from the wild type. This is in a contrast to the H1069Q mutation within the same α-HH, which greatly destabilizes protein both in vitro and in cells. The difference between two mutants can be linked to a lower stability of the α-HH in the H1069Q variant at the physiological temperature. We conclude that the structural stability of the N-domain rather than the loss of ATP binding plays a defining role in the ability of ATP7B to reach the trans-Golgi network, thus contributing to phenotypic variability in WD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21398519      PMCID: PMC3091241          DOI: 10.1074/jbc.M110.198101

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  The role of the invariant His-1069 in folding and function of the Wilson's disease protein, the human copper-transporting ATPase ATP7B.

Authors:  Ruslan Tsivkovskii; Roman G Efremov; Svetlana Lutsenko
Journal:  J Biol Chem       Date:  2003-01-27       Impact factor: 5.157

2.  NH2-terminal signals in ATP7B Cu-ATPase mediate its Cu-dependent anterograde traffic in polarized hepatic cells.

Authors:  Y Guo; L Nyasae; L T Braiterman; A L Hubbard
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-06-30       Impact factor: 4.052

3.  Novel ATP7B mutations causing Wilson disease in several Israeli ethnic groups.

Authors:  H Kalinsky; A Funes; A Zeldin; Y Pel-Or; M Korostishevsky; R Gershoni-Baruch; L A Farrer; B Bonne-Tamir
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

4.  High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis.

Authors:  K Caca; P Ferenci; H J Kühn; C Polli; H Willgerodt; B Kunath; W Hermann; J Mössner; F Berr
Journal:  J Hepatol       Date:  2001-11       Impact factor: 25.083

5.  Distribution of patients with Wilson disease carrying the H1069Q mutation in Austria.

Authors:  E Cauza; H Ulrich-Pur; C Polli; A Gangl; P Ferenci
Journal:  Wien Klin Wochenschr       Date:  2000-07-07       Impact factor: 1.704

6.  The H1069Q mutation in ATP7B is associated with late and neurologic presentation in Wilson disease: results of a meta-analysis.

Authors:  Janneke M Stapelbroek; Casper W Bollen; Johannes K Ploos van Amstel; Karel J van Erpecum; Jan van Hattum; Leonard H van den Berg; Leo W J Klomp; Roderick H J Houwen
Journal:  J Hepatol       Date:  2004-11       Impact factor: 25.083

7.  Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation.

Authors:  A S Payne; E J Kelly; J D Gitlin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

8.  [ATP7B gene mutations in Hungarian patients with Wilson disease--case reports to illustrate the diverse clinical presentations].

Authors:  Anikó Folhoffer; Andrea Horváth; Dalma Hegedüs; Gábor Firneisz; Kinga Dunkel; Claudia Willheim; Péter Ferenci; László Szönyi; Margit Abonyi; Péter László Lakatos; Ferenc Szalay
Journal:  Orv Hetil       Date:  2003-12-21       Impact factor: 0.540

9.  The distinct functional properties of the nucleotide-binding domain of ATP7B, the human copper-transporting ATPase: analysis of the Wilson disease mutations E1064A, H1069Q, R1151H, and C1104F.

Authors:  Clinton T Morgan; Ruslan Tsivkovskii; Yuri A Kosinsky; Roman G Efremov; Svetlana Lutsenko
Journal:  J Biol Chem       Date:  2004-06-17       Impact factor: 5.157

10.  Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell lines.

Authors:  Dominik Huster; Michael Hoppert; Svetlana Lutsenko; Jan Zinke; Claudia Lehmann; Joachim Mössner; Frieder Berr; Karel Caca
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

View more
  16 in total

1.  Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition.

Authors:  Elena Arystarkhova; Ihtsham U Haq; Timothy Luebbert; Fanny Mochel; Rachel Saunders-Pullman; Susan B Bressman; Polina Feschenko; Cynthia Salazar; Jared F Cook; Scott Demarest; Allison Brashear; Laurie J Ozelius; Kathleen J Sweadner
Journal:  Neurobiol Dis       Date:  2019-08-16       Impact factor: 5.996

Review 2.  Genetics and epigenetic factors of Wilson disease.

Authors:  Valentina Medici; Janine M LaSalle
Journal:  Ann Transl Med       Date:  2019-04

3.  Mapping the ATP binding site in the plasma membrane H(+)-ATPase from Kluyveromyces lactis.

Authors:  José G Sampedro; Hugo Nájera; Salvador Uribe-Carvajal; Yadira G Ruiz-Granados
Journal:  J Fluoresc       Date:  2014-10-28       Impact factor: 2.217

4.  A structural model of the copper ATPase ATP7B to facilitate analysis of Wilson disease-causing mutations and studies of the transport mechanism.

Authors:  Maya Schushan; Ashima Bhattacharjee; Nir Ben-Tal; Svetlana Lutsenko
Journal:  Metallomics       Date:  2012-06-13       Impact factor: 4.526

Review 5.  The genetics of Wilson disease.

Authors:  Irene J Chang; Si Houn Hahn
Journal:  Handb Clin Neurol       Date:  2017

Review 6.  Golgi in copper homeostasis: a view from the membrane trafficking field.

Authors:  Roman Polishchuk; Svetlana Lutsenko
Journal:  Histochem Cell Biol       Date:  2013-07-12       Impact factor: 4.304

Review 7.  Modifying factors and phenotypic diversity in Wilson's disease.

Authors:  Svetlana Lutsenko
Journal:  Ann N Y Acad Sci       Date:  2014-04-04       Impact factor: 5.691

8.  Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B.

Authors:  Lelita T Braiterman; Amrutha Murthy; Samuel Jayakanthan; Lydia Nyasae; Eric Tzeng; Grazyna Gromadzka; Thomas B Woolf; Svetlana Lutsenko; Ann L Hubbard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

9.  Linkage disequilibrium and haplotype analysis of the ATP7B gene in Alzheimer's disease.

Authors:  Rosanna Squitti; Renato Polimanti; Serena Bucossi; Mariacarla Ventriglia; Stefania Mariani; Dario Manfellotto; Fabrizio Vernieri; Emanuele Cassetta; Francesca Ursini; Paolo Maria Rossini
Journal:  Rejuvenation Res       Date:  2013-02       Impact factor: 4.663

10.  Conformations of the apo-, substrate-bound and phosphate-bound ATP-binding domain of the Cu(II) ATPase CopB illustrate coupling of domain movement to the catalytic cycle.

Authors:  Samuel Jayakanthan; Sue A Roberts; Andrzej Weichsel; José M Argüello; Megan M McEvoy
Journal:  Biosci Rep       Date:  2012-10       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.